Insmed, Inc. (INSM)
148.31
+9.17
(+6.59%)
USD |
NASDAQ |
Mar 25, 16:00
148.10
-0.21
(-0.14%)
After-Hours: 20:00
Insmed Cash from Investing (Quarterly) : 389.41M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 27.58M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Revolution Medicines, Inc. | 74.88M |
| Amicus Therapeutics, Inc. | -6.494M |
| PTC Therapeutics, Inc. | 34.01M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -247.60M |
| Cash from Financing (Quarterly) | 33.86M |
| Free Cash Flow | -997.58M |
| Free Cash Flow Per Share (Quarterly) | -1.377 |
| Free Cash Flow to Equity (Quarterly) | -305.09M |
| Free Cash Flow to Firm (Quarterly) | -273.49M |
| Free Cash Flow Yield | -3.38% |